Diltiazem Hci Injection
Product Images NDC 51662-1335

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Diltiazem Hci (NDC 51662-1335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Diltiazem HCl, illustrating the molecular composition and bonding pattern of the active ingredient in the drug product.*

FDA Label Image

Dosage (Dosage 1)

Table showing dilution and administration information for DILTIAZEM HCI Injection, with data on diluent volume, quantity of injection to add, final concentration, dose, and infusion rate for different preparation volumes (100 mL, 250 mL, 500 mL).*

FDA Label Image

Logo (Logo)

FDA Label Image

Vial Label (Vial Label)

Label for Diltiazem HCl Injection 25 mg/5 mL (5 mg/mL) in a 5 mL single-dose vial. The label specifies use for direct IV bolus injection and continuous IV infusion. It includes storage instructions to keep refrigerated at 2°-8°C (36°-46°F) and discard unused portions. The labeler is listed as West-Ward, Eaton, NJ, USA.*

FDA Label Image

Label On Vial (Labeled Vial)

Diltiazem HCl Injection 25 mg/5 mL (5 mg/mL) in a 5 mL single-dose vial with a blue cap. The label states it is for direct IV bolus injection and continuous IV infusion. The vial is brown with a white and blue label. The product NDC shown is 0641-6013-01.*

FDA Label Image

Serialized Labeling (Serialized Labeling)

DILTIAZEM HCI 5 mg/mL injection in a 5 mL amber glass single-dose vial with a blue flip-off cap. The white and blue label shows the proprietary name and strength for intravenous use. A barcode label is attached, indicating distribution by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Pouch Labeling (51662 1335 2 Pouch Labeling)

Label for DILTIAZEM HCl Injection 25 mg/5 mL (5 mg/mL) vial by HF Acquisition Co LLC, DBA HealthFirst. The label includes the NDC 51662-1335-2, lot number 123456, and expiration date 2030-01-01. It specifies the intravenous injection dosage form and mentions storage instructions and composition details.*

FDA Label Image

Serialized Rfid Labeling (51662 1335 2 Pouch Rfid Labeling)

The image shows a barcode label on a white package with a QR code and human-readable text including a numeric code (01) 00351662133521, a date (17) 300101, and other identifiers. It mentions distribution by HF Acquisition Co., LLC in Mukilteo, WA. The label is for DILTIAZEM HCI injection, 5 mg/mL, by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial Label (51662 1335 2 Vial Label)

Label for Diltiazem HCl Injection, 5 mg/mL (25 mg per 5 mL) in a 5 mL single dose vial. Intended for intravenous bolus injection and continuous IV infusion. The label includes storage instructions, manufacturer details (Hikma, Berkeley Heights, NJ), and usage notes such as discarding unused portions and refrigeration requirements (2° to 8°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.